ETF Managers Group’s Strata Critical Medical SRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTA
ETF Managers Group's SRTA Position: Q1 2023 in Review
ETF Managers Group reduced its Strata Critical Medical (SRTA) stake by 41% in Q1 2023, selling an estimated $1.32M and leaving 464,962 shares worth $1.57M. The position accounts for 0.05% of the portfolio, ranked #164.
ETF Managers Group first reported a position in SRTA in Q3 2021 and has held it in 7 quarters since. The position peaked at $7.07M in Q1 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.
- ETF Managers Group held 464,962 shares of Strata Critical Medical worth $1.57M as of Q1 2023.
- ETF Managers Group sold 323,651 Strata Critical Medical shares in Q1 2023, an estimated $1.32M.
- Strata Critical Medical made up 0.05% of ETF Managers Group's portfolio in Q1 2023, its #164 holding.
- ETF Managers Group first reported a position in Strata Critical Medical in Q3 2021 and has held it in 7 quarters since.
- ETF Managers Group's Strata Critical Medical position peaked at $7.07M in Q1 2022.
- 93 funds tracked by Wall St. Rank held Strata Critical Medical as of Q1 2023.
Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.